华兰股份 (301093.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

86.8x

Market Cap

CNY 16.72B

MomentumView details →

1D Return

−4.33%

YTD Return

+22.11%

RSI (14)

35.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

86.8x

Market Cap

CNY 16.72B

RSI (14)

35.7

MomentumView details →

1D Return

−4.33%

YTD Return

+22.11%

ProfitabilityView details →

Gross Margin

38.81%

Net Margin

7.03%

EBITDA Margin

25.10%

ROE (TTM)

1.92%

ROA (TTM)

1.68%

Asset Turnover

0.24x

GrowthView details →

Revenue YoY

−0.33%

EPS YoY

−24.10%

FCF YoY

+91.39%

Revenue CAGR 3Y

+1.98%

EPS CAGR 3Y

−19.21%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

9.41x

Quick Ratio

8.57x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

603.43M

Net Income (TTM)

42.41M

Op. CF (TTM)

133.39M

Latest newsMore news →

Hualan Stock formulates the Information Disclosure Affairs Management System for Debt Financing Instruments in the Interbank Bond Market.39d ago

Hualan Stock adjusts its wholly-owned subsidiary Hainan Lingqing Digital Pharmaceutical Technology Co., Ltd.'s investment in Wuxi Natural Constant Technology Co., Ltd.39d ago

Similar companies

威孚高科000581.SZ 木林森002745.SZ 广和通300638.SZ 和而泰002402.SZ 民爆光电301362.SZ 稳健医疗300888.SZ

Latest newsMore news →

Hualan Stock formulates the Information Disclosure Affairs Management System for Debt Financing Instruments in the Interbank Bond Market.39d ago Hualan Stock adjusts its wholly-owned subsidiary Hainan Lingqing Digital Pharmaceutical Technology Co., Ltd.'s investment in Wuxi Natural Constant Technology Co., Ltd.39d ago